-+ 0.00%
-+ 0.00%
-+ 0.00%

Outset Medical says HCA refresh amendment calls for about $40 million Tablo system purchases through 2028

PUBT·06/17/2026 20:06:23
Listen to the news
Outset Medical says HCA refresh amendment calls for about $40 million Tablo system purchases through 2028
  • Outset Medical entered a refresh amendment to its purchasing agreement with HCA on June 14, 2026.
  • HCA committed to buy new Tablo Hemodialysis Systems from 2026 through 2028 for an aggregate contract value of about $40 million, net.
  • Deal also sets a console and consumables purchase framework to support potential expansion beyond current Tablo-adopting HCA hospitals.
  • Outset reiterated its 2026 guidance, with financial impact details to follow once implementation timing becomes clearer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outset Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-274135), on June 17, 2026, and is solely responsible for the information contained therein.